Tacrolimus monotherapy in OLT [orthotopic liver transplant] recipients with HCV [hepatitis C virus] under preemptive treatment with interferon and ribavirin

Trial Profile

Tacrolimus monotherapy in OLT [orthotopic liver transplant] recipients with HCV [hepatitis C virus] under preemptive treatment with interferon and ribavirin

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 18 Nov 2013

At a glance

  • Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Feb 2012 Planned End Date changed from 1 Jul 2009 to 1 Mar 2008 as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov record.
    • 03 Nov 2009 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top